Hersh David S, Moore Kenneth, Nguyen Vincent, Elijovich Lucas, Choudhri Asim F, Lee-Diaz Jorge A, Khan Raja B, Vaughn Brandy, Klimo Paul
Departments of1Neurosurgery and.
2Neurology, University of Tennessee Health Science Center.
J Neurosurg Pediatr. 2019 Sep 20;24(6):680-688. doi: 10.3171/2019.7.PEDS19188. Print 2019 Dec 1.
Stenoocclusive cerebral vasculopathy is an infrequent delayed complication of ionizing radiation. It has been well described with photon-based radiation therapy but less so following proton-beam radiotherapy. The authors report their recent institutional experience in evaluating and treating children with radiation-induced cerebral vasculopathy.
Eligible patients were age 21 years or younger who had a history of cranial radiation and subsequently developed vascular narrowing detected by MR arteriography that was significant enough to warrant cerebral angiography, with or without ischemic symptoms. The study period was January 2011 to March 2019.
Thirty-one patients met the study inclusion criteria. Their median age was 12 years, and 18 (58%) were male. Proton-beam radiation therapy was used in 20 patients (64.5%) and photon-based radiation therapy was used in 11 patients (35.5%). Patients were most commonly referred for workup as a result of incidental findings on surveillance tumor imaging (n = 23; 74.2%). Proton-beam patients had a shorter median time from radiotherapy to catheter angiography (24.1 months [IQR 16.8-35.4 months]) than patients who underwent photon-based radiation therapy (48.2 months [IQR 26.6-61.1 months]; p = 0.04). Eighteen hemispheres were revascularized in 15 patients. One surgical patient suffered a contralateral hemispheric infarct 2 weeks after revascularization; no child treated medically (aspirin) has had a stroke to date. The median follow-up duration was 29.2 months (IQR 21.8-54.0 months) from the date of the first catheter angiogram to last clinic visit.
All children who receive cranial radiation therapy from any source, particularly if the parasellar region was involved and the child was young at the time of treatment, require close surveillance for the development of vasculopathy. A structured and detailed evaluation is necessary to determine optimal treatment.
狭窄闭塞性脑血管病是电离辐射罕见的延迟并发症。基于光子的放射治疗对此已有详细描述,但质子束放射治疗后较少见。作者报告了他们近期在评估和治疗儿童放射性脑血管病方面的机构经验。
符合条件的患者年龄在21岁及以下,有颅脑放疗史,随后经磁共振血管造影检测到血管狭窄,严重程度足以进行脑血管造影,无论有无缺血症状。研究期间为2011年1月至2019年3月。
31例患者符合研究纳入标准。他们的中位年龄为12岁,18例(58%)为男性。20例患者(64.5%)采用质子束放射治疗,11例患者(35.5%)采用基于光子的放射治疗。患者最常见的情况是因监测肿瘤成像时的偶然发现而被转诊进行检查(n = 23;74.2%)。质子束治疗患者从放疗到导管血管造影的中位时间(24.1个月[四分位间距16.8 - 35.4个月])比接受基于光子放射治疗的患者(48.2个月[四分位间距26.6 - 61.1个月])短;p = 0.04。15例患者的18个半球进行了血管重建。1例手术患者在血管重建后2周出现对侧半球梗死;迄今为止,接受药物治疗(阿司匹林)的儿童均未发生中风。从首次导管血管造影到最后一次门诊就诊的中位随访时间为29.2个月(四分位间距21.8 - 54.0个月)。
所有接受任何来源颅脑放射治疗的儿童,特别是如果鞍旁区域受累且治疗时年龄较小,都需要密切监测血管病的发生。进行结构化和详细的评估对于确定最佳治疗方案是必要的。